Top

Familial Cancer

Published in:

01-04-2001 | Commentary

Commentary on Eccles et al.: Familial breast cancer: an investigation into the outcome of treatment for early stage disease

Authors: Julia Wong, Judy Garber

Published in: Familial Cancer | Issue 2/2001

Title: Commentary on Eccles et al.: Familial breast cancer: an investigation into the outcome of treatment for early stage disease
Authors: Julia Wong
Judy Garber
Publication date: 01-04-2001
Publisher: Kluwer Academic Publishers
Published in: Familial Cancer / Issue 2/2001
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1023/A:1013844807960

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2001

FAP associated thyroid carcinoma in mother and her daughter

Familial breast cancer: an investigation into the outcome of treatment for early stage disease

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study

Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features

Desmoid tumour in familial adenomatous polyposis. A review of literature

Preventive measures in Peutz-Jeghers syndrome

Keynote webinar | Spotlight on antibody–drug conjugates in cancer